STEWARTVILLE, Minn.,
April 7, 2011 /PRNewswire/ --
Rochester Medical Corporation (NASDAQ: ROCM) today announced that
it has now completed the previously announced purchase of Laprolan
B.V., the former Medical Supplies Division and wholly owned
subsidiary of Fornix BioSciences N.V. Under the terms of the
purchase agreement the purchase is deemed retroactive to
January 1, 2011. For more
information regarding this transaction please refer to the
Company's January 12, 2011 press
release. The Company plans to further discuss this acquisition in
its second quarter financial results press release and conference
call which is expected to be held in early May, 2011.
Rochester Medical Corporation develops, manufactures, and
markets latex-free disposable medical catheters and devices for
urological and continence care applications. The Company
markets under its own Rochester Medical® brand and under existing
private label arrangements.
For further information, please contact Anthony J. Conway, President and Chief Executive
Officer or David A. Jonas, Chief
Financial Officer of Rochester Medical Corporation at (507)
533-9600. More information about Rochester Medical is
available on its website at http://www.rocm.com.
SOURCE Rochester Medical Corporation